The Carlyle Group Inc. Stock Price, News & Analysis

Carlyle (NASDAQ: CG), a global investment firm, has announced its intention to offer senior notes, subject to market conditions. The notes will be guaranteed by several Carlyle subsidiaries including Carlyle Holdings I L.P., Carlyle Holdings II L.L.C., Carlyle Holdings III L.P., and CG Subsidiary Holdings L.L.C.

The company plans to use the proceeds for general corporate purposes. The offering is being managed by major financial institutions including Citigroup, Goldman Sachs, J.P. Morgan, Morgan Stanley, and Wells Fargo Securities as joint book-running managers. Carlyle currently manages $465 billion in assets across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest, with over 2,300 employees in 27 offices globally.

Carlyle (NASDAQ: CG) has agreed to acquire intelliflo from Invesco (NYSE: IVZ) for up to $200 million. The deal includes a $135 million payment at closing and potential future earn-outs of up to $65 million.

intelliflo is a leading cloud-based practice management software provider serving over 30,000 professionals at 2,600 advisory firms, managing approximately £450 billion in client assets. The transaction includes intelliflo's US subsidiaries, which will be established as a standalone business called RedBlack.

The acquisition will be funded by Carlyle Europe Technology Partners V, a €3 billion fund. The deal is expected to close in Q4 2025, subject to closing conditions. The separation will allow both intelliflo and RedBlack to focus on their respective markets - UK/Australia and US respectively.

CommScope (NASDAQ: COMM) has announced a transformative deal to sell its Connectivity and Cable Solutions (CCS) segment to Amphenol Corporation (NYSE: APH) for $10.5 billion in cash. The transaction is expected to close in the first half of 2026, subject to regulatory approvals and shareholder vote.

The Company anticipates net proceeds of approximately $10 billion after taxes and expenses. CommScope plans to repay all debt, redeem preferred equity held by Carlyle, and distribute significant excess cash to shareholders as a dividend within 60-90 days post-closing. The remaining business will focus on ANS and RUCKUS segments, continuing to develop next-generation network connectivity solutions.

Warburg Pincus and Carlyle (NASDAQ: CG) have announced an agreement to sell NEOGOV, a leading provider of HR and compliance software for U.S. public sector agencies, to EQT X fund and CPP Investments. Founded in 2000, NEOGOV serves nearly 10,000 public sector organizations across North America with its cloud-native suite supporting the complete employee lifecycle.

During their nine-year partnership, NEOGOV has significantly expanded its platform and product suite while maintaining consistent top-line growth. Warburg Pincus, having invested over $36 billion in technology companies, and Carlyle have played crucial roles in NEOGOV's strategic development and market expansion.

Carlyle (NASDAQ: CG) has announced an agreement to acquire a majority stake in Adastra Group SE, a global IT consultancy specializing in AI, data, and cloud transformations. Founded in 2000 and headquartered in Prague and Toronto, Adastra employs over 2,000 professionals across North America, Europe, and Asia.

The investment will be jointly provided by Carlyle Europe Technology Partners V and Carlyle Asia Partners Growth II. The acquisition aims to support Adastra's growth in data, cloud, and AI offerings through organic investments and targeted M&A. The deal is subject to regulatory approvals in multiple jurisdictions.

SS&C Technologies (Nasdaq: SSNC) has announced a definitive agreement to acquire Calastone, the largest global funds network, from Carlyle for £766 million (US $1.03 billion). Calastone connects over 4,500 financial organizations across 57 markets, with the deal expected to close in Q4 2025.

The acquisition will integrate Calastone's 250+ employees into SS&C Global Investor & Distribution Solutions. The strategic combination aims to create a unified, real-time operating platform, enhancing fund distribution and operational efficiency. SS&C expects the acquisition to be accretive within 12 months and will finance it through a combination of debt and cash on hand.

Trucordia has secured a significant $1.3 billion strategic investment from Carlyle's Global Credit platform, valuing the company at $5.7 billion. The transaction, expected to close in June 2025, aims to reduce Trucordia's leverage and streamline governance by repurchasing units from minority investors. As a top 20 U.S. insurance brokerage, Trucordia offers commercial and personal lines, life, and employee benefits insurance solutions. The investment will strengthen the company's financial structure and provide flexibility for strategic growth. The deal was led by Carlyle's Credit Opportunities team, part of their Global Credit platform which manages $199 billion in assets. J.P. Morgan served as advisor and placement agent, while Orrick, Herrington & Sutcliffe LLP and Latham & Watkins LLP provided legal counsel to Trucordia and Carlyle respectively.

bluebird bio has been acquired by Carlyle and SK Capital, transitioning from a public to private company. The acquisition brings significant primary capital to support the scaling of bluebird's commercial gene therapy treatments for sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy. New CEO David Meek, along with a refreshed management team, will lead the company's transformation from scientific innovator to commercial leader. The company plans to focus on expanding manufacturing infrastructure, improving patient access, streamlining treatment processes, and strengthening payer partnerships. The strategic backing from Carlyle and SK Capital aims to help meet growing demand and drive operational excellence.

Carlyle and SK Capital Partners have announced the successful completion of their tender offer for bluebird bio (NASDAQ: BLUE). The offer, which expired on May 29, 2025, resulted in approximately 59.8% of bluebird's outstanding shares (5,868,196 shares) being validly tendered. Shareholders had the option to receive either $3.00 per share plus a contingent value right (CVR) worth $6.84 if bluebird achieves $600 million in net sales before December 31, 2027, or a flat $5.00 per share in cash. With all conditions satisfied, the acquisition is expected to close on June 2, 2025, through a merger under Delaware law Section 251(h), requiring no additional shareholder vote.